A Study Assessing the Safety and Pharmacokinetic Profile of Modified Release Formulations of Tolcapone

NCT03633591 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Tolcapone
DRUG: Tolcapone Modified Release Prototype
DRUG: Tolcapone Divided Dose
DRUG: Tolcapone Modified Release Prototype

Sponsor

Corino Therapeutics, Inc.

Collaborators

[object Object]